Sci-Tech World Delaware: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Delaware.

Press releases published on June 9, 2026

Jun. 9, 2026

Printify Shows Creators How to Sell Art on Etsy in 2026

Indeterminate EIN Presswire

Jun. 9, 2026

Printify Reveals the Best-Selling Items on Etsy for 2026

Indeterminate EIN Presswire

Jun. 9, 2026

UK firms embrace AI boom, but leadership gap threatens growth

Indeterminate GlobeNewswire

Jun. 9, 2026

BlockchAIn Announces Closing of $55 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 9, 2026

XM Partner Code 274PQ: What It Is, How It Works, and How to Use It in 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

BETMAT Quantitative Endotoxin Analysis System for Enhanced Testing Precision

Indeterminate EIN Presswire

Jun. 9, 2026

Close Launches Chloe, an AI Sales Agent Built Directly Into the CRM

Indeterminate GlobeNewswire

Jun. 9, 2026

Applied Digital Announces Pricing of $1.59 Billion of Senior Secured Notes to fund the Fourth Building at Polaris Forge 1

Indeterminate GlobeNewswire

Jun. 9, 2026

How Does BETMAT RCR Assay Support the Transition from LAL to Recombinant Endotoxin Testing in BET Solutions

Indeterminate EIN Presswire

Jun. 9, 2026

Can BETMAT Sustainable rFC Endotoxin Testing Improve Parenteral Drug Quality Control

Indeterminate EIN Presswire

Jun. 9, 2026

Technical Guide: Implementing Kinetic Chromogenic LAL Reagent for Quantitative BET Applications in Pharmaceutical QC

Indeterminate EIN Presswire

Jun. 9, 2026

Einride, a Global Leader in Autonomous and Electric Freight, Completes Business Combination and Will Begin Trading on Nasdaq Stock Market

Indeterminate GlobeNewswire

Jun. 9, 2026

Enhance Quality Control with BETMAT’s Kinetic Chromogenic LAL Reagent for Quantitative BET Applications

Indeterminate EIN Presswire

Jun. 9, 2026

BETMAT Kinetic Turbidimetric Assay (KTA) Safeguards Pharmaceutical Endotoxin Testing with Reliable Advanced Detection

Indeterminate EIN Presswire

Jun. 9, 2026

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

Indeterminate GlobeNewswire

Jun. 9, 2026

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire

Indeterminate GlobeNewswire

Jun. 9, 2026

Big Digital Energy, Inc. Terminates Existing Stockholder Rights Agreement

Indeterminate GlobeNewswire

Jun. 9, 2026

OpenEnvoy Launches Ask OE to Solve Enterprise Finance AI's Foundational Problem

Indeterminate GlobeNewswire

Jun. 9, 2026

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

Indeterminate GlobeNewswire

Jun. 9, 2026

Shattuck Labs, Inc. Announces Proposed Public Offering

Indeterminate GlobeNewswire